Wireless Health: Personalized Medicine Comes to the Device Industry

This is the device industry's wireless wake-up call. With all the speed and acceleration of an advancing information technology industry, forces outside of the medical device industry are driving shifts in medical product markets and business models. Those forces include the consumerization. globalization, systematization, and economies of scale created by IT. Wireless medicine enables connectivity between caregivers and patients, continuous monitoring of patients with chronic diseases, and a new paradigm for personalized medicine, one based on the patterns that can be gleaned from enormous volumes of individualized patient data, rather than on blood-based biomarkers.

The wireless revolution in health care won't just add another gadget to the toolbox of medical product manufacturers. Wireless health is a trend that sees the consumerization, systematization, globalization, and the economies of scale made possible by information technology disrupting the practice of medicine and medical markets. What began, six years or so ago in the hands of medical device companies like Royal Philips Electronics NV, and Medtronic PLC, and BioTelemetry Inc. as "remote monitoring," a way for companies to reach patients with chronic diseases in their homes, is rapidly snowballing into a new paradigm for improving care, increasing access to care, and making care affordable. This new wave in medicine is being driven by outsiders—by wireless providers like Qualcomm, the cell phone manufacturers Nokia and Apple Computer, MicroSoft and other software companies, and manufacturers of internet networking equipment like Cisco--that are simply leveraging their enormous installed bases to get into new high-growth markets in health care. According to Andrew Thompson, CEO of "intelligent medicine" company Proteus Digital Health Inc., by 2010, four billion people in the world will own cell phones, 50% of them by people that make less than $10 a day. That's an enormous infrastructure for reaching individuals in their homes, and therefore, for targeting chronic diseases.

Proteus Biomedical describes the potential of the field this way, in a company presentation: "What if my cell phone alerted me when my father needed help with his Parkinson's? What...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

FDA Rebukes Four Companies, Including One Overseas, For Procedural Failures

 

The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.

EU Finalizes Framework For Joint Clinical Assessments Of High-Risk Devices

 

Second submission window for joint scientific consultations on a procedure to help prepare for joint clinical assessments will open from 2 to 30 June 2025.

Get Ready For International Harmonization Before Approaching QMSR Deadline, Says Regulatory Expert

 

During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.

UK Take Care! Regulatory And Market Access Reforms Must Not Shut Out Medtech Growth

 
• By 

Speakers at a recent UK medtech outlook conference voiced optimism about the sector’s prospects, but warned that cost burdens, over-regulation and lengthy processes will impede the capacity of local SMEs to innovate. Only 10% of NHS procured medtech comes from UK manufacturers.

More from Medtech Insight

Get Ready For International Harmonization Before Approaching QMSR Deadline, Says Regulatory Expert

 

During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.

Handheld Diagnostics: A Resurging Category That is Here to Stay

 

Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.

Execs On The Move: 12-23 May 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.